Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous mesna added to usual care for acute pancreatitis
IRCT20121021011192N19Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mesna in acute pancreatitis (AP) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Decrease of C-reactive protein compared with baseline and C-reactive protein at day 3. Started Nov 2024; status: completed.
02
Drugs
mesna
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on IRCT20121021011192N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121021011192N19.